Life Technologies, TGen, US Oncology collaborate to sequence genomes of triple negati
Life Technologies Corporation today announced that it is collaborating with the Translational Genomics Research Institute and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies.
More...
|